WHO ICTRP trial
A Single-centre, Double-blind, Double-dummy, Randomised, Crossover Study to…
EUCTR2008-008656-16-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-008656-16-GB |
|---|---|
| Public title | A Single-centre, Double-blind, Double-dummy, Randomised, Crossover Study to investigate the effect of Formoterol HFA-pMDI versus Salmeterol HFA-pMDI on small airways physiological parameters in COPD patients. IMPERIAL Study - IMPERIAL Study |
| Scientific title | A Single-centre, Double-blind, Double-dummy, Randomised, Crossover Study to investigate the effect of Formoterol HFA-pMDI versus Salmeterol HFA-pMDI on small airways physiological parameters in COPD patients. IMPERIAL Study - IMPERIAL Study |
| Primary sponsor | Chiesi Farmaceutici SpA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | United Kingdom |
| Conditions | COPD MedDRA version: 14.0 Level: LLT Classification code 10009032 Term: Chronic obstructive lung disease System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders |
| Interventions | Trade Name: Atimos® 12µg Pharmaceutical Form: Pressurised inhalation, solution INN or Proposed INN: Formoterol Fumarate CAS Number: 43229-80-7 Concentration unit: µg microgram(s) Concentration type: equal Concentration number: 12… |
| Registration date | Jan 10, 2009 |
| Target size | 40 |
| Secondary IDs | CCD-0901-PR-0012 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: